Company intelligence / Profile preview
Collgard Biopharmaceuticals
Petah Tikva, Center District, Israelpitchbook.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Collgard Biopharmaceuticals develops drug treatments that modulate tissue regeneration, primarily by targeting collagen pathways. Their lead compound, halofuginone hydrobromide, has been investigated for multiple indications including vascular restenosis and fibrosis. Some programs have reached clinical stages but the highest known phase for their main asset is discontinued in at least one indication (bladder cancer). The company maintains collaborations with major academic and clinical institutions.
- Therapeutic areas
- DermatologyOncologyCardiovascularOther
- Modalities
- Small moleculeCollagen inhibitor
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Mayo ClinicU.S. National Cancer Institute (NCI)European Organisation for Research and Treatment of Cancer (EORTC)Harvard Medical School
Beyond the preview
Go deeper on Collgard Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Collgard Biopharmaceuticals.